Skip to main content
. 2024 Jan 1;8(1):33–47. doi: 10.7150/ntno.85092

Table 1.

In-vitro characterization of non-targeted and fibrin-targeted formulations

Formulation Particle Size (nm) Concentration of OFP (mg/mL) (%) Lipid Content (mg/mL) Zeta Potential (mV) pH
Non-targeted MBs
PSMBs
880.00 ± 11.11
245.51 ± 42.05
7.24 ± 0.21
88.28 ± 2.57
DPPE-MPEG-5K= 0.256
DPPC= 0.495
DPPE=0.044
Total lipid content= 0.795
-0.234 6.49
Fibrin- targeted MBs
PSMBs
820.00 ± 34.00
149.91 ± 33.15
6.73 ± 0.30
86.34 ± 3.91
DPPE-MPEG-5K= 0.295
DPPC= 0.417
DPPE=0.050
Total lipid content= 0.760
-0.611 6.45